About Deific Life Sciences Private Limited
Data last updated:
Deific Life Sciences Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 March 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2017PTC315003. Its GSTIN is 07AAGCD0936P2ZA (Delhi). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sumit Kumar Meena and Shweta Meena.
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Office No A – 114 – 115 Rg City Centre Motia Khan, New Delhi, Delhi, India – 110092.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website deificlifesciences.com.
Company details
Contact details
Deific Life Sciences Private Limited's registered office is in New Delhi, Delhi. Its website is deificlifesciences.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered AddressOffice No A – 114 – 115 Rg City Centre Motia Khan, New Delhi, Delhi, India – 110092
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Deific Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Deific Life Sciences Private Limited
FY 2025 filings availableDeific Life Sciences Private Limited reported revenue of ₹5,560 (down 97% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 83% over three years, including a 97% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹5,560 | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Deific Life Sciences Private Limited, buy the company report.
Board of directors of Deific Life Sciences Private Limited
Deific Life Sciences has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shweta Meena | Additional Director | 30 Jul 2018 | 8 Years 2 Months | Current |
| Ram Swaroop Meena | Additional Director | 28 Dec 2018 | 7 Years 9 Months | Current |
| Sumit Kumar Meena Also directs: GTP Green India Private Limited, Deific Trading Private Limited | Director | 23 Mar 2017 | 9 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving Deific Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Deific Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Deific Life Sciences has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAGCD0936P2ZA | Delhi | Active | 01 May 2018 |
To see the full GST registrations and return filing status of Deific Life Sciences Private Limited, buy the company report.
Recent activity
Deific Life Sciences Private Limited has 4 board changes on record since 2017: 3 appointments and 1 cessation. The latest: Ram Swaroop Meena was appointed as Additional Director on 28 Dec 2018.
Frequently asked questions
Deific Life Sciences is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 March 2017 (9+ years old) and is registered under CIN U51909DL2017PTC315003.
Deific Life Sciences has 3 current directors:
- Shweta Meena - Additional Director
- Ram Swaroop Meena - Additional Director
- Sumit Kumar Meena - Director
The latest financial statements of Deific Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 25 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Deific Life Sciences is 07AAGCD0936P2ZA, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Deific Life Sciences is U51909DL2017PTC315003. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Deific Life Sciences was incorporated on 23 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
Ram Swaroop Meena was appointed as Additional Director on 28 Dec 2018. Ajit Kumar Meena ceased to be Director on 11 Aug 2018. Shweta Meena was appointed as Additional Director on 30 Jul 2018. Deific Life Sciences has 4 board changes on record in total.
Deific Life Sciences can be reached through the website deificlifesciences.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Deific Life Sciences is at Office No A – 114 – 115 Rg City Centre Motia Khan, New Delhi, Delhi, India – 110092.
Deific Life Sciences operates in the pharma industry, in the drug formulation and development segment.